[1]
2011. Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. Drugs and Therapy Studies. 2, 1 (Dec. 2011), e1. DOI:https://doi.org/10.4081/dts.2012.e1.